These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5961035)

  • 21. [Findings of the real value of sulphonotherapy in the programs of prevention of leprosy].
    Lima Lde S
    Rev Bras Leprol; 1968-1969; 36(1):31-6. PubMed ID: 5748409
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism of action of sulfones.
    Bergel M
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):89-90. PubMed ID: 7195883
    [No Abstract]   [Full Text] [Related]  

  • 23. The etiology of erythema nodosum leprosum.
    Pettit JH; Waters MF
    Int J Lepr Other Mycobact Dis; 1967; 35(1):1-10. PubMed ID: 6067035
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of sulphone resistant leprosy--a review of sixty one cases.
    Seshadri PS; Ravi NT
    Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of the leprous reaction].
    Bergel M
    Ther Ggw; 1971 Oct; 110(10):1471-6. PubMed ID: 5003860
    [No Abstract]   [Full Text] [Related]  

  • 26. Intra-articular corticosteroid preparations: different characteristics and their effect during inflammation induced by monosodium urate crystals in the rat subcutaneous air pouch.
    Rull M; Clayburne G; Sieck M; Schumacher HR
    Rheumatology (Oxford); 2003 Sep; 42(9):1093-100. PubMed ID: 12777646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of bacilloscopy practiced on 360 leprosy patients, treated for over 5 years by sulfone monotherapy and examined at Bamako (Mali)].
    Baquillon G; Ferracci C; Ridel PR; Saint-André P; Pattyn SR
    Acta Leprol; 1981; 85():25-39. PubMed ID: 6805233
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative tests of glucosulfone sodium (promin), thiocarlid (lsoxyl), and two INH-derivatives with Stefansky-leprosy of the white rat.
    Meyer-Rohn J
    Int J Lepr Other Mycobact Dis; 1971; 39(2):354-7. PubMed ID: 5169804
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Sulphone resistance in leprosy.
    Crawford CL
    Lancet; 1975 Aug; 2(7928):280. PubMed ID: 49828
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transition of leprous occular changes under chemotherapy].
    Arai M
    Keisei Geka; 1967 Apr; 10(2):Suppl:7-9. PubMed ID: 6070441
    [No Abstract]   [Full Text] [Related]  

  • 31. Control of leprosy.
    Lechat MF
    Lepr Rev; 1969 Oct; 40(4):191-4. PubMed ID: 5385243
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of leprosy.
    Singh RP
    Indian J Dermatol; 1966 Jul; 11(4):151-2. PubMed ID: 5969952
    [No Abstract]   [Full Text] [Related]  

  • 33. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials.
    Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):319-27. PubMed ID: 14750577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroids for treating nerve damage in leprosy. A Cochrane review.
    van Veen NH; Nicholls PG; Smith WC; Richardus JH
    Lepr Rev; 2008 Dec; 79(4):361-71. PubMed ID: 19274983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of leprosy in the Central European region].
    Hermans EH
    Internist (Berl); 1966 Dec; 7(12):602 passim. PubMed ID: 4870024
    [No Abstract]   [Full Text] [Related]  

  • 36. Steroid therapy and leprosy.
    Ramu G
    Indian J Lepr; 1996; 68(2):182-3. PubMed ID: 8835589
    [No Abstract]   [Full Text] [Related]  

  • 37. Involvement of scalp in leprosy.
    Mukhopadhyay AK
    Indian J Lepr; 2005; 77(1):47-50. PubMed ID: 16173419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Control of leprosy: fantasies and possibilities].
    Browne SG
    Acta Leprol; 1980; (81):27-33. PubMed ID: 6785980
    [No Abstract]   [Full Text] [Related]  

  • 39. [Corticosteroid prevention of hyaline membrane disease].
    Tiufekchieva E; Tomanov V
    Akush Ginekol (Sofiia); 1984; 23(3):225-33. PubMed ID: 6236707
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical and hormonal experiences with a steroid combination].
    Boni M; Luvarà A
    Reumatismo; 1969; 21(5):335-9. PubMed ID: 5404989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.